Breast Implants Market Size, Share, Opportunities, And Trends By Product (Silicone Breast Implants, Saline Breast Implants), By Shape (Round, Anatomical), By Application (Reconstructive Surgery, Cosmetic Surgery), And By Geography - Forecasts From 2023 To 2028

The breast implants market was valued at US$1.601 billion in 2021 and is expected to grow at a CAGR of 6.68% during the forecast period.

Breast implants are medical devices used to enhance the size and shape of a woman's breasts through surgical procedures. They are primarily used for cosmetic purposes. The rising prevalence of breast cancer along with the increasing beauty consciousness and awareness about breast reconstruction is contemplated to boost the breast implants market. Moreover, technological advancements in the implant system and rising disposable income are further expected to aid the breast implants market.

Rising Prevalence of Breast Cancer

Breast implants are commonly used in breast reconstruction procedures after mastectomy (surgical removal of one or both breasts) due to breast cancer. Therefore, the rising cases of breast cancer is expected to propel the breast implants market. Breast cancer is the most prevalent cancer of all types around the globe. For instance, there were around 2.3 million new instances of breast cancer in 2020, and there were approximately 685 000 deaths from the condition in the world as per the International Agency for Research on Cancer (IARC). Moreover, it is estimated by the IARC that there will be more than 3 million new instances of breast cancer annually (an increase of 40%) and more than 1 million annual fatalities (an increase of 50%) by 2040.

Increasing Beauty Consciousness

In recent years, there has been a growing trend of people seeking cosmetic enhancements to improve their physical appearance. The increasing emphasis on beauty and body image in society has driven the breast implants market. For instance, according to the 2023 annual Global Survey on Aesthetic/Cosmetic Procedures conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), plastic surgeons worldwide reported a significant increase of 19.3% in overall procedures performed in 2021. The survey revealed that more than 12.8 million surgical procedures and approximately 17.5 million non-surgical procedures were conducted globally during that year. Moreover, breast augmentation was the most common surgical procedure for women according to the same survey.

Advancements in Implant Technology

Technological innovations in breast implant materials and design have improved the safety, durability, and natural appearance of implants. Advancements in implant surfaces, such as textured implants, have helped reduce the risk of implant rotation and capsular contracture thereby propelling the breast implants market. For example, modern breast implants often use cohesive silicone gel, which maintains its shape and integrity even if the implant shell is compromised. Nanotechnology has influenced breast implant development by creating nanostructured surfaces that enhance tissue integration and reduce complications like capsular contracture. Moreover, advanced 3D imaging and simulation technologies allow patients to visualize potential outcomes before undergoing surgery and thus helps in improved decision making.

Rising Disposable Income

Economic prosperity and increasing disposable income in various regions have allowed more individuals to afford cosmetic procedures, making breast implants more accessible to a broader demographic. Therefore, rising disposable income is expected to bolster the breast implants market. For instance, according to the Ministry of Statistics and Program Implementation, the gross disposable income of India witnessed a growth of 6.4% in the fiscal year 2019-20, reaching a total of Rs. 204.22 lakh crore. Moreover, according to the data from the National Bureau of Statistics, China's per capita disposable income was 35,128 yuan (about $5,523) in 2021, an increase of 9.1% year over year in nominal terms.

Restraints in the Market

The breast implants market has experienced growth and development however some restraints or challenges can impact its expansion. For example, the cost of the implants itself, the surgeon's fees, the anesthesia, and the post-operative care may all add up to a significant expense for breast implant treatments. Therefore, affordability might be a limiting factor for some people which may negatively impact the market expansion. Issues such as implant rupture, capsular contracture, implant-associated anaplastic large cell lymphoma (BIA-ALCL), and potential long-term health effects have raised questions about the safety profile of breast implants. These concerns have led to increased scrutiny by health authorities and regulatory bodies thereby potentially affecting consumer confidence and market demand.

North America is Expected to Grow Significantly

North America is expected to hold a significant share of the breast implants market during the forecast period. The factors attributed to such a share are rising breast cancer cases, increasing disposable income, a strong healthcare system, and earlier adoption of technological advancements. For instance, breast cancer is the second highest diagnosed cancer in the USA contributing to around 30% of all new female cancers each year according to the American Cancer Society. Moreover, breast augmentation is one of the top 5 surgical procedures in America as per the American Society of Plastic Surgeons 2020 report.

Major Market Players

• Polytech Health & Aesthetics GmbH is a German company specializing in the development and manufacturing of medical devices, particularly breast implants and products for plastic and reconstructive surgery. Polytech Patient Pathway™ and B-Lite® lightweight implants are offered by the company for breast implants.
• Motiva Implants is a brand of breast implants known for its focus on innovation, safety, and patient-centered design. Motiva offers a range of ergonomic gel-filled breast implants called Ergonomix. These implants were designed to adapt to the patient's movements and provide a more natural appearance.
• Groupe Sebbin SAS is a French company specializing in the development, manufacturing, and distribution of medical devices, particularly breast implants and products for plastic and reconstructive surgery. The breast implant solutions offered by the company are Sensity, Volupty, Purity, and Integrity.

Key Market Developments

• In January 2022, the Mentor® MemoryGel BOOST™ breast implant developed by Mentor Worldwide LLC was granted FDA approval. It is designed for breast augmentation in women aged 22 years at least and breast reconstruction for women of all ages.
• In May 2021, GC Aesthetics launched next generation of breast implants PERLE™. It features a proprietary surface technology BioQ™, Emunomic™ breast tissue dynamic gel, and an enhanced version of safety features.
• In November 2021, GC Aesthetics launched a minimal touch implant insertion device HydroCone. It is a sterile and single-patient-use device made of hydraulic acid that enables  more efficient surgeries.

Segmentation:

• By Product
  • Silicone Breast Implants
  • Saline Breast Implants
• By Shape
  • Round
  • Anatomical
• By Application
  • Reconstructive Surgery
  • Cosmetic Surgery
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others